Verona Pharma Plc (DELISTED) (VRNA:DL)
106.91
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 16:00
Verona Pharma Total Liabilities (Quarterly): 294.60M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 77.64B |
| AstraZeneca PLC | 68.48B |
| GSK Plc | 61.37B |
| Haleon Plc | -- |
| Adaptimmune Therapeutics Plc | 201.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 572.87M |
| Shareholders Equity (Quarterly) | 278.27M |
| Debt to Equity Ratio | 0.8782 |
| Current Ratio | 10.71 |
| Net Debt Paydown Yield | -0.47% |